Thermo Fisher stock gains after strong Q2 and upbeat 2026 outlook
Published on 09/16/2026 at 15:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific stock (ISIN US8835561023) closed at USD 641.39 on the New York Stock Exchange on September 15, 2026, up 4.61 percent from the prior session and drawing renewed attention from investors to the company’s growth story.
Q2 2026 growth and outlook support the move
According to an analysis summarizing Thermo Fisher Scientific’s presentation at the Morgan Stanley 24th Annual Global Healthcare Conference, the company delivered strong Q2 2026 results, with organic revenue growth and earnings per share exceeding expectations, helped by robust demand from pharma, biotech and industrial customers.TradingView For Q2 2026, the commentary notes that Thermo Fisher achieved mid single-digit organic revenue growth and delivered year-over-year EPS growth that surpassed prior guidance, underpinning management’s confidence in a robust multi-year outlook.TradingView
As summarized in that conference transcript, management highlighted that demand linked to artificial intelligence, data center activity and reshoring trends is supporting orders across multiple segments, contributing to stronger than previously anticipated growth in 2026 and beyond.TradingView For investors, this combination of stronger organic growth and an improving demand backdrop explains why the stock’s latest price move has been accompanied by renewed interest in the shares.
Stock reaction and recent price dynamics
Per data cited by MarketWatch, Thermo Fisher stock closed at USD 641.39 on September 15, 2026, representing a gain of USD 28.24 or 4.61 percent versus the prior close, with a pre-open indication of USD 641.00 ahead of the next trading session.Morningstar A separate overview of strong US stocks reported that Thermo Fisher shares recently traded at USD 635.55, up 3.65 percent on the day, with an intraday high of USD 637.03 and low of USD 614.13, underlining that the stock has been moving higher in recent sessions on rising volume.TTV
An article discussing the stock’s valuation pointed out that at around USD 641.39 on September 15, 2026, Thermo Fisher was trading above some fair value estimates, which could keep attention on how far earnings and cash flow can grow to support the higher price level.Yahoo Finance For context, another trading-focused report noted that the shares around USD 637.82 were up 3.93 percent in a recent session after Thermo Fisher announced new Heratherm environmental chambers, showing that both operational developments and broader growth expectations are influencing day-to-day price moves.Traders Union
Conference signals and analyst perspective
Notes from the Morgan Stanley healthcare conference in September 2026 indicate that Thermo Fisher’s top management sees orders arriving ahead of prior expectations across all major business areas and described 2026 as a potentially outstanding year for the company.Finmarket In that analysis, an investment firm noted that, in light of these improved prospects, its rating and target price for Thermo Fisher are under review, reflecting a reassessment of the upside potential as the company’s outlook strengthens.Finmarket
At the same time, commentary from trading and valuation platforms stresses that Thermo Fisher’s share price has moved above some fair value estimates, implying that further upside will likely depend on the company continuing to deliver organic growth and EPS improvements at least in line with the Q2 2026 performance.Morningstar For investors, the key balance is between the stronger multi-year demand picture described at the conference and the valuation risk that arises when the stock trades at a premium to certain fair value assessments.
Stock price level and investor takeaway
Thermo Fisher stock’s most recent reference price on the New York Stock Exchange was USD 641.39 as of September 15, 2026, with that closing level marking a 4.61 percent daily increase that outpaced many peers and followed earlier intraday gains around the USD 635 area.Yahoo Finance The recent price strength, combined with confirmation at the Morgan Stanley conference that orders are running ahead of expectations and that Q2 2026 organic growth and EPS exceeded guidance, leaves Thermo Fisher stock supported by an improving operating backdrop, even as valuation has become a more prominent consideration.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Trading venue: NYSE
- Price (as of September 15, 2026, 4:00): 641.39 USD
- Sector / Industry: Health care equipment and services
- Index membership: S&P 500
